FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Comparative study of FEV1 /FVC and FEV1 /FEV6 to screen COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005
Exercise capacity and gas exchange in smokers with discordant GOLD vs FEV1/FVC lower limit of normal (LLN) airway obstruction diagnosis. Source: International Congress 2019 – Cardiopulmonary exercise testing Year: 2019
Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016
FEV1/FEV6 versus FEV1/FVC in the spirometric detection of airway obstruction among Asians Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Distinguishing hyperinflation from combined restriction in patients with reduced FEV1 /FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Lung function testing in the elderly – can we still use FEV1/FVC < 70% as a criterion of COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007
Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
FEV6 as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Are FEV6, FVC and VC different in diagnosing obstructive ventilatory defect? Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Comparison of prebronchodilator FEV1/FEV6 of handheld spirometry with postbronchodilator FEV1/FVC of spirometry in Korea: a pilot study Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Prevalence of abnormal lung volumes, DLCO and chest HRCT in smokers with normal spirometry Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013